New Singaporean investor iGlobe Partners backs rapidly developing preclinical pipeline at immunotherapy pioneer’s company

Co-inventor of Trocept platform to guide immuno-oncology pipeline growth

Primavera Venture Partners and Birk Venture among first investors.